Biology Reference
In-Depth Information
232. Bartram J, Cairncross S. Hygiene, sanitation, and water: forgotten foundations of
health. PLoS Med 2010;
7
:e1000367.
233. Plaisier AP, van Oortmarssen GJ, Habbema JD, Remme J, Alley ES. ONCHOSIM:
a model and computer simulation program for the transmission and control of
onchocerciasis. Comput Methods Programs Biomed 1990;
31
:43
56.
234. Plaisier AP, Subramanian S, Das PK, et al. The LYMFASIM simulation program for
modeling lymphatic filariasis and its control. Methods Inf Med 1998;
37
:97
e
108.
235. Vlas SJ, Van Oortmarssen GJ, Gryseels B, Polderman AM, Plaisier AP, Habbema JD.
SCHISTOSIM: a microsimulation model for the epidemiology and control of schisto-
somiasis. Am J Trop Med Hyg 1996;
55
:170
e
5.
236. Stolk WA, de Vlas SJ, Borsboom GJJM, Habbema JDF. LYMFASIM, a simulation model
for predicting the impact of lymphatic filariasis control: quantification for African
villages. Parasitology 2008;
135
:1583
e
98.
237. Winnen M, Plaisier AP, Alley ES, et al. Can ivermectin mass treatments eliminate
onchocerciasis in Africa? Bull World Health Organ 2002;
80
:384
e
91.
238. Churcher TS, Bas´ ˜ ez M- G. Sampling strategies to detect anthelmintic resistance: the
perspective of human onchocerciasis. Trends Parasitol 2009;
25
:11
e
7.
239. Montresor A, Gyorkos TW, Crompton DWT, Bundy DAP, Savioli L. Monitoring
helminth control programmes. Guidlines for monitoring the impact of control pro-
grammes aimed at reducing morbidity caused by soil-transmitted helminths and
schistosomes, with particular reference to school-age children. Geneva: World Health
Organization; 1999.
240. Farrington CP. Modelling forces of infection for measles, mumps and rubella. Stat Med
1990;
9
:953
e
67.
241. Stepek G, Buttle DJ, Duce IR, Behnke JM. Human gastrointestinal nematode infections:
are new control methods required? Int J Exp Pathol 2006;
87
:325
e
41.
242. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth
infections. JAMA 2008;
299
:1937
e
e
48.
243. Belizario VY, Amarillo ME, de Leon WU. de los Reyes AE, Bugayong MG, Macatangay
BJC. A comparison of the efficacy of single doses of albendazole, ivermectin, and
diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull
World Health Organ 2003;
81
:35
42.
244. Mani TR, Rajendran R, Munirathinam A, et al. Efficacy of co-administration of
albendazole and diethylcarbamazine against geohelminthiases: a study from South
India. Trop Med Int Health 2002;
7
:541
e
8.
245. Arfaa F, Ghadirian E. Epidemiology and mass-treatment of ascariasis in six rural
communities in central Iran. Am J Trop Med Hyg 1977;
26
:866
e
71.
246. Seo BS, Cho SY, Chai JY. Frequency distribution of Ascaris lumbricoides in rural Koreans
with special reference on the effect of changing endemicity. Korean J Parasitol
1979;
17
:105
e
13.
247. Seo BS, Cho SY, Chai JY, Hong ST. Comparative efficacy of interval mass treatment on
Ascaris lumbricoides infection in Korea. Korean J Parasitol 1980;
18
:145
e
51.
248. Seo BS, Chai JY. Effect of two-month interval mass chemotherapy on the reinfection of
Ascaris lumbricoides in Korea. Korean J Parasitol 1980;
18
:153
e
63.
249. Martin J, Keymer A, Isherwood RJ, Wainwright SM. The prevalence and intensity of
Ascaris lumbricoides infections in Moslem children from northern Bangladesh. Trans R
Soc Trop Med Hyg 1983;
77
:702
e
6.
250. Cabrera BD. Reinfection and infection rates of ascariasis in relation to seasonal
variation in the Philippines. Southeast Asian J Trop Med Public Health 1984;
15
:394
e
401.
251. Holland CV, Crompton DW, Taren DL, et al. Ascaris lumbricoides infection in pre-school
children from Chiriqui Province, Panama. Parasitology 1987;
95
:615
e
e
22.
